Bladder Cancer was the indication approved by FDA for immunotherapy. The most common and standard way in bladder cancer immunotherapy is intravesically in which bladder cancer treated with the drug BCG with help of catheter into urethra.
Other immunotherapies include oncolytic virus therapy, immune modulators, cancer vaccines and monoclonal antibodies. It mostly begins in transitional epithelial cells that is involved in the make up of inner lining of bladder.
Related Journals of Bladder Cancer Immunotherapy
Immunotherapy: Open Access, Immunooncology journal, Immunome Research journal, Immunology Journal, Immunobiology journal, Advances in Urology, Nature International weekly journal of science, Dovepress, The journal of Urology, Nature Reviews Cancer.
